Skip to main content

News Archive

News Archive - All Stories

Private Support Leads to Transformative Advances in Ocean Ingenuity at Scripps

September 12, 2014

Gismos, gadgets, widgets ... Ingenuity in developing precise and efficient tools is an important key to unlocking the mysteries of the ocean. Observing the oceans in real time is crucial to understanding and protecting the planet. Private support can make a significant difference in the speed with which new oceanographic technologies are developed and put into use.

Krstic Wins Chestnut Textbook Prize

September 12, 2014

Miroslav Krstic, professor of mechanical and aerospace engineering and associate vice chancellor for research at UC San Diego, has received the triennial Chestnut Textbook Prize awarded by the International Federation of Automatic Control (IFAC).

In Rats and Men, Nicotine Withdrawal Casts Similar Pall

September 12, 2014

In a set of novel experiments involving both humans and rats, researchers at the University of California, San Diego School of Medicine, Florida Atlantic University (FAU), University of Pittsburgh, Washington University and Harvard Medical School report that the brain’s response to reward – its ability to recognize and derive pleasure from natural stimuli such as food, money or sex – is measurably reduced after nicotine withdrawal.

Scientists Discover Neurochemical Imbalance in Schizophrenia

September 11, 2014

Using human induced pluripotent stem cells (hiPSCs), researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California, San Diego have discovered that neurons from patients with schizophrenia secrete higher amounts of three neurotransmitters broadly implicated in a range of psychiatric disorders.

Ferrara Receives Champalimaud Award for Role in Eye Disease Therapy

September 10, 2014

Napoleone Ferrara, MD, Distinguished Professor of Pathology and Distinguished Adjunct Professor of Ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the António Champalimaud Vision Award in Lisbon, Portugal.

Autism Early Detection Program Expands

September 10, 2014

Autism spectrum disorder (ASD) is now estimated to impact one in every 68 children born in the United States. A new 5-year, $5.1 million grant from the National Institute of Mental Health (NIMH) seeks expand a program developed by researchers at University of California, San Diego School of Medicine to reduce the mean age of ASD diagnosis in multiple cities across the U.S.

Computer scientists launch Kickstarter for video game that teaches kids how to code

September 10, 2014

Computer scientists at the University of California, San Diego have successfully funded on Kickstarter a new and improved version of CodeSpells, a first-person player game they developed that teaches players how to code.

Lasers could make hard drives faster, simpler and higher density

September 9, 2014

Researchers at the University of California, San Diego have discovered that for a wide range of ferromagnetic materials the direction of magnetization can be completely controlled by polarized light without the need for magnetic fields, a finding that could significantly affect the data memory and storage industries that produce hard disks and magnetic random access memories. Their research, published Aug. 21 in the journal Science Express, focused on materials currently being developed for high-density storage applications.

UC San Diego Researchers Build First 500 GHz Photon Switch

September 9, 2014

The work took nearly four years to complete and it opens a fundamentally new direction in photonics – with far-reaching potential consequences for the control of photons in optical fiber channels.

Clinical Trial To Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes

September 9, 2014

Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
Category navigation with Social links